Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001415889-23-002168

CHIEF MEDICAL OFFICER gave up 1,242 shares (to pay taxes)

  • CHIEF MEDICAL OFFICER acquired 5,833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gelder Mark S. MD CHIEF MEDICAL OFFICER 2023-02-07 Option exercise +5,833 11,729 D
Gelder Mark S. MD CHIEF MEDICAL OFFICER 2023-02-07 Shares withheld for taxes −1,242 $1.36 $1,689 10,487 D
Derivatives
Gelder Mark S. MD CHIEF MEDICAL OFFICER 2023-02-07 Option exercise · Restricted Stock Units −5,833 11,667 D
Loading xslF345X03/form4-02082023_100255.xml…